|
|
| What's the Deal at Solvay?
| | | By
Walter Armstrong
| | | The Belgian drugmaker is pursuing a sale, inking deals, issuing debt, and launching a power drug for Parkinson's—all at once.
| | | A Hard Pill to Swallow
| | | By
George Koroneos, Online Content & News Editor
| | | Innovative pharmaceutical companies are reaching out to physicians and consumers in an effort to get patients to take their medicine.
| | | Betting the Pharma
| | | By
Walter Armstrong
| | | With the biotech industry reeling from the recession, big drugmakers hold all the cards when it comes to making deals, but picking a winner is still a gamble. Here are 10 to place stakes on.
| |
|
|
|
| The Art and Science of a Global Brand
| | | To navigate the global marketplace, pharma companies have to mobilize a multifaceted team with the training to turn raw data into meaningful insights.
| | | With One Voice
| | | In an era of blurred channels and information clutter, it is critical for brand managers to develop a unified strategy that bridges the gaps between audiences.
| |
|
|
|
| If It Walks Like a Duck
| |
| | By
Peter Pitts
| | | Dietary supplements function like drugs and are marketed like drugs. They should be regulated like ducks.
| |
|
|
|
| Sweeten the Pill
| | | Through innovative patient compliance programs, manufacturers are taking steps to meet the needs of patients and the pharma industry.
| |
|
|
|
| Lemonade 101
| | | By
Sander A. Flaum
| | | Business schools must prepare students for the post-recession economy, not teach them principles applicable to 2003.
| |
|
|
|
| Coverage Vs. Control
| | | By
Jill Wechsler
| | | Pressure to expand healthcare puts drug pricing, marketing, and innovation on the negotiating table.
| |
|